Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naive settings.

ABSTRACT:

SUBMITTER: Garcia JS 

PROVIDER: S-EPMC10122101 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature